Matches in SemOpenAlex for { <https://semopenalex.org/work/W2414583284> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W2414583284 endingPage "22" @default.
- W2414583284 startingPage "419" @default.
- W2414583284 abstract "Experimental evidence of the cytotoxic activity of two new agents was obtained using five lines of human breast carcinoma serially transplanted into immunosuppressed mice. Tumor growth delay was used to compare the effect of the new agents with that of cytotoxic drugs of known value in human breast cancer. The mean specific growth delay (number of tumor volume doubling times saved) for each agent against the five lines was: CL232/315 (mitoxantrone) 1.9; M-AMSA (4'[9 - acridinyl] amino-methane sulphon - M - ansidine) 0.5; cyclophosphamide, 1.9; adriamycin, 1.8; melphalan 2.2. There was no significant difference between the activity of mitoxantrone and the clinically useful drugs, but m-AMSA (amsacrine) was significantly less active than the other agents. A clinical trial of mitoxantrone at the Royal Marsden Hospital has confirmed the prediction of useful activity against breast cancer. Objective responses (CR + PR, UICC response criteria) were noted in 21 out of 70 (30%) patients with advanced breast cancer treated with the drug. The responses were of 4-7 months plus duration, and the 30% response rate compares favorably with other single agents. Although amsacrine is active in many forms of malignant disease, several Phase II studies have shown it to have little effect in breast cancer. By using panels of xenografts of different tumor types, it should be possible to select the most appropriate human tumors against which to test a new cytotoxic agent in Phase II studies." @default.
- W2414583284 created "2016-06-24" @default.
- W2414583284 creator A5002943156 @default.
- W2414583284 creator A5073006057 @default.
- W2414583284 date "1985-07-01" @default.
- W2414583284 modified "2023-09-26" @default.
- W2414583284 title "Correlation between experimentally and clinically demonstrated activity of two new cytotoxic agents in breast cancer." @default.
- W2414583284 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/3839994" @default.
- W2414583284 hasPublicationYear "1985" @default.
- W2414583284 type Work @default.
- W2414583284 sameAs 2414583284 @default.
- W2414583284 citedByCount "2" @default.
- W2414583284 crossrefType "journal-article" @default.
- W2414583284 hasAuthorship W2414583284A5002943156 @default.
- W2414583284 hasAuthorship W2414583284A5073006057 @default.
- W2414583284 hasConcept C121608353 @default.
- W2414583284 hasConcept C126322002 @default.
- W2414583284 hasConcept C143998085 @default.
- W2414583284 hasConcept C154317977 @default.
- W2414583284 hasConcept C202751555 @default.
- W2414583284 hasConcept C2776694085 @default.
- W2414583284 hasConcept C2776755627 @default.
- W2414583284 hasConcept C2778001805 @default.
- W2414583284 hasConcept C2778119113 @default.
- W2414583284 hasConcept C2778684742 @default.
- W2414583284 hasConcept C2780500152 @default.
- W2414583284 hasConcept C2780923524 @default.
- W2414583284 hasConcept C3018521938 @default.
- W2414583284 hasConcept C530470458 @default.
- W2414583284 hasConcept C55493867 @default.
- W2414583284 hasConcept C71924100 @default.
- W2414583284 hasConcept C86803240 @default.
- W2414583284 hasConcept C98274493 @default.
- W2414583284 hasConceptScore W2414583284C121608353 @default.
- W2414583284 hasConceptScore W2414583284C126322002 @default.
- W2414583284 hasConceptScore W2414583284C143998085 @default.
- W2414583284 hasConceptScore W2414583284C154317977 @default.
- W2414583284 hasConceptScore W2414583284C202751555 @default.
- W2414583284 hasConceptScore W2414583284C2776694085 @default.
- W2414583284 hasConceptScore W2414583284C2776755627 @default.
- W2414583284 hasConceptScore W2414583284C2778001805 @default.
- W2414583284 hasConceptScore W2414583284C2778119113 @default.
- W2414583284 hasConceptScore W2414583284C2778684742 @default.
- W2414583284 hasConceptScore W2414583284C2780500152 @default.
- W2414583284 hasConceptScore W2414583284C2780923524 @default.
- W2414583284 hasConceptScore W2414583284C3018521938 @default.
- W2414583284 hasConceptScore W2414583284C530470458 @default.
- W2414583284 hasConceptScore W2414583284C55493867 @default.
- W2414583284 hasConceptScore W2414583284C71924100 @default.
- W2414583284 hasConceptScore W2414583284C86803240 @default.
- W2414583284 hasConceptScore W2414583284C98274493 @default.
- W2414583284 hasIssue "4" @default.
- W2414583284 hasLocation W24145832841 @default.
- W2414583284 hasOpenAccess W2414583284 @default.
- W2414583284 hasPrimaryLocation W24145832841 @default.
- W2414583284 hasRelatedWork W132710811 @default.
- W2414583284 hasRelatedWork W1966338330 @default.
- W2414583284 hasRelatedWork W1990916592 @default.
- W2414583284 hasRelatedWork W2060816095 @default.
- W2414583284 hasRelatedWork W2064930805 @default.
- W2414583284 hasRelatedWork W2080323787 @default.
- W2414583284 hasRelatedWork W2412848401 @default.
- W2414583284 hasRelatedWork W2414583284 @default.
- W2414583284 hasRelatedWork W2421304553 @default.
- W2414583284 hasRelatedWork W4206561586 @default.
- W2414583284 hasVolume "5" @default.
- W2414583284 isParatext "false" @default.
- W2414583284 isRetracted "false" @default.
- W2414583284 magId "2414583284" @default.
- W2414583284 workType "article" @default.